H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 108 Citations 35,221 567 World Ranking 2619 National Ranking 1522

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Gene

Loic Le Marchand focuses on Internal medicine, Odds ratio, Genetics, Genome-wide association study and Oncology. His Internal medicine study often links to related topics such as Genotype. The study incorporates disciplines such as Gastroenterology, Lung cancer, Case-control study and Confidence interval in addition to Odds ratio.

His Case-control study research focuses on Risk factor and how it connects with Overweight. His Genome-wide association study research is included under the broader classification of Single-nucleotide polymorphism. Loic Le Marchand interconnects Epidemiology, Lynch syndrome, Young adult, Microsatellite instability and Prospective cohort study in the investigation of issues within Oncology.

His most cited work include:

  • MicroRNA related polymorphisms and breast cancer risk (582 citations)
  • Detectable clonal mosaicism from birth to old age and its relationship to cancer (389 citations)
  • Identification of seven new prostate cancer susceptibility loci through a genome-wide association study (385 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Oncology, Cancer, Genome-wide association study and Genetics. His Internal medicine study frequently involves adjacent topics like Endocrinology. In his research, Prostate is intimately related to Prostate cancer, which falls under the overarching field of Oncology.

The Cancer study which covers Gerontology that intersects with Obesity. Single-nucleotide polymorphism covers Loic Le Marchand research in Genome-wide association study. His study explores the link between Odds ratio and topics such as Confidence interval that cross with problems in Proportional hazards model.

He most often published in these fields:

  • Internal medicine (50.06%)
  • Oncology (32.35%)
  • Cancer (25.54%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (50.06%)
  • Oncology (32.35%)
  • Cancer (25.54%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Internal medicine, Oncology, Cancer, Colorectal cancer and Genome-wide association study. His study in Odds ratio, Confidence interval, Multiethnic cohort, Lung cancer and Breast cancer is done as part of Internal medicine. His Odds ratio research is multidisciplinary, incorporating perspectives in Epidemiology, Case-control study and Disease.

His Oncology study also includes

  • Endometrial cancer which intersects with area such as Ovarian cancer,
  • Body mass index which intersects with area such as Obesity. His research investigates the connection between Cancer and topics such as Cohort that intersect with problems in Family history. His Genome-wide association study study is within the categories of Single-nucleotide polymorphism and Genetics.

Between 2019 and 2021, his most popular works were:

  • Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database (96 citations)
  • Cumulative Burden of Colorectal Cancer Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer (27 citations)
  • Physical activity and risks of breast and colorectal cancer : a Mendelian randomisation analysis (21 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

Loic Le Marchand mostly deals with Internal medicine, Oncology, Cancer, Colorectal cancer and Odds ratio. His work on Internal medicine is being expanded to include thematically relevant topics such as Genome-wide association study. His Genome-wide association study research is under the purview of Single-nucleotide polymorphism.

His Oncology research includes themes of Elevated PSA, Multiethnic population, Carcinogenesis, Prostate cancer and Endometrial cancer. His study in Colorectal cancer is interdisciplinary in nature, drawing from both Mendelian randomization and Mendelian Randomization Analysis. His Odds ratio study combines topics in areas such as Prospective cohort study, Logistic regression, Case-control study and Disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

MicroRNA related polymorphisms and breast cancer risk

Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne.
PLOS ONE (2014)

582 Citations

Animal fat consumption and prostate cancer: a prospective study in Hawaii.

Loic Le Marchand;Laurence N. Kolonel;Lynne R. Wilkens;Beth C. Myers.
Epidemiology (1994)

473 Citations

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

Rosalind A. Eeles;Zsofia Kote-Jarai;Ali Amin Al Olama;Graham G. Giles;Graham G. Giles.
Nature Genetics (2009)

455 Citations

Identification of Lynch syndrome among patients with colorectal cancer

Leticia Moreira;Francesc Balaguer;Noralane Lindor;Albert De La Chapelle.
JAMA (2012)

450 Citations

Detectable clonal mosaicism from birth to old age and its relationship to cancer

Cathy C. Laurie;Cecelia A Laurie;Kenneth Rice;Kimberly F. Doheny.
Nature Genetics (2012)

445 Citations

Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

Montserrat Garcia-Closas;Per Hall;Heli Nevanlinna;Karen Pooley.
PLOS Genetics (2008)

441 Citations

A common genetic risk factor for colorectal and prostate cancer.

Christopher A Haiman;Loïc Le Marchand;Jennifer Yamamato;Daniel O Stram.
Nature Genetics (2007)

415 Citations

Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico

A. L. Williams Amy;A. L. Williams Amy;S. B R Jacobs Suzanne;Hortensia Moreno-Macías;Alicia Huerta-Chagoya.
Nature (2014)

397 Citations

Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash.

Montserrat García-Closas;Kathleen M. Egan;Jeannine Abruzzo;Polly A. Newcomb;Polly A. Newcomb.
Cancer Epidemiology, Biomarkers & Prevention (2001)

394 Citations

Associations of CYP1A1, GSTM1, and CYP2E1 Polymorphisms with Lung Cancer Suggest Cell Type Specificities to Tobacco Carcinogens

Loïc Le Marchand;Lakshmi Sivaraman;Lisa Pierce;Ann Seifried.
Cancer Research (1998)

373 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Loic Le Marchand

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 388

Stephen J. Chanock

Stephen J. Chanock

National Institutes of Health

Publications: 263

John L. Hopper

John L. Hopper

University of Melbourne

Publications: 252

Wei Zheng

Wei Zheng

Vanderbilt University Medical Center

Publications: 238

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 205

Paul D.P. Pharoah

Paul D.P. Pharoah

University of Cambridge

Publications: 197

Douglas F. Easton

Douglas F. Easton

University of Cambridge

Publications: 195

Christopher A. Haiman

Christopher A. Haiman

University of Southern California

Publications: 191

David J. Hunter

David J. Hunter

University of Oxford

Publications: 189

John D. Potter

John D. Potter

Massey University

Publications: 187

Peter Kraft

Peter Kraft

Harvard University

Publications: 185

Melissa C. Southey

Melissa C. Southey

Cancer Council Victoria

Publications: 185

Roger L. Milne

Roger L. Milne

Cancer Council Victoria

Publications: 183

Andrew T. Chan

Andrew T. Chan

Harvard University

Publications: 170

Xiao-Ou Shu

Xiao-Ou Shu

Vanderbilt University Medical Center

Publications: 168

Walter C. Willett

Walter C. Willett

Harvard University

Publications: 167

Something went wrong. Please try again later.